Inactive Instrument

Lannett Company, Inc. Stock price Nyse MKT

Equities

LCI

US5160121019

Pharmaceuticals

Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 63 18-01-01
Chief Tech/Sci/R&D Officer - 98-12-31
Corporate Officer/Principal - 11-12-31
Members of the board TitleAgeSince
Director/Board Member - -
Chairman - 23-06-15
Director/Board Member 50 23-06-15
More insiders
Lannett Company, Inc. is engaged in the development, manufacturing, marketing and distribution of generic versions of brand pharmaceutical products. The Company markets approximately 100 products, mainly tablet, capsule or liquid oral generic medications. Its marketed products include generics such as Posaconazole, Fluphenazine, Levothyroxine, Sumatriptan and NDA-based product Numbrino. The Company's product portfolio include Amphetamine IR Tablets, which are used to treat Attention deficit hyperactivity disorder (ADHD) and narcolepsy; Dicyclomine tablets, used for the treatment of functional bowel disorder and irritable bowel syndrome; Levothyroxine Capsules, used to treat patients with hypothyroidism and other conditions, and Numbrino Nasal Solution, used for the induction of local anesthesia of the mucous membranes when performing diagnostic procedures and surgeries on or through the nasal cavities in adults, among others.
More about the company
  1. Stock
  2. Equities
  3. Stock Lannett Company, Inc.
  4. Stock Lannett Company, Inc. - Nyse MKT